title: Is sulphadoxine-pyrimethamine (SP) still useful as the first-line antimalarial drug in Malawi or it must be quickly withdrawn from the antimalarial repertoire?
authors.affiliation: Malawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi. Email: snkhoma@mlw.medcol.mw or s24nkhoma@yahoo.co.uk.
authors.forename: Standwell
authors.initials: S
authors.lastname: Nkhoma